Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status

Otolaryngology - Head and Neck Surgery (United States)

Volumn 151, Issue 4, 2014, Pages 606-611

  Ford, Samuel E ^a   Brandwein Gensler, Margaret ^b   Carroll, William R ^c   Rosenthal, Eben L ^c   Magnuson, J Scott ^d  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d FLORIDA HOSPITAL   (United States)

Author keywords

carcinoma; HPV; human papillomavirus; oropharynx; p16; p16 INK4a; robotic; surgery; survival; TORS; transoral

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OPEN SURGICAL APPROACH; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PATIENT REFERRAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; ROBOTICS; SURGICAL APPROACH; SURGICAL TECHNIQUE; TANSORAL ROBOTIC; TERTIARY HEALTH CARE; UNITED STATES; WART VIRUS; AGED; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; ISOLATION AND PURIFICATION; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PATHOLOGY; ROBOTIC SURGICAL PROCEDURE; TREATMENT OUTCOME; VIROLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; RETROSPECTIVE STUDIES; ROBOTIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84908884368     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814542939     Document Type: Review

References (13)

1. The United States Food and Drug Administration: 510(k) summary, section III: indications for use for Intuitive surgical endoscopic instrument control system. 2009.
2. Weinstein GS, O'Malley BW, Magnuson JS, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope. 2012 ; 122: 1701-1707
3. National Cancer Institute. SEER fact stat sheets: oral cavity and pharynx. seer.cancer.gov/statfacts/html/oralcav.html. Updated November2011. Accessed January 2013.
4. Centers for Disease Control and Prevention. HPV-associated oropharyngeal cancer rates by race and ethnicity. http://www.cdc.gov/cancer/hpv/statistics/headneck.htm. Updated August2012. Accessed January 2013.
5. Cohen MA, Weinstein GS, O'Malley BW, Feldman M, Quon H. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011 ; 33: 573-580
6. Haughey BH, Hinni ML, Salassa JR. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011 ; 33: 1683-1694
7. Hurtuk AM, Marcinow A, Agarwal A, Old M, Teknos TN, Ozer E. Quality-of-life in transoral robotic surgery. Otolaryngol Head Neck Surg. 2012 ; 146: 68-73
8. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc. 2012 ; 87: 219-225
9. Weinstein GS, O'Malley BW, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010 ; 136: 1079-1085
10. White HN, Moore EJ, Rosenthal EL, et al. Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and two-year survival analysis. Arch Otolaryngol Head Neck Surg. 2010 ; 136: 1248-1252
11. HolsingerFC, Radiation Therapy Oncology Group, National Cancer Institute. Radiation therapy and cisplatin with or without surgery in treating patients with stage III-IV oropharyngeal cancer. http://clinicaltrials.gov/show/NCT01953952. NLM Identifier: NCT01953952.
12. FerrisRL, Eastern Cooperative Oncology Group, National Cancer Institute. Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer. http://clinicaltrials.gov/show/NCT01898494. NLM Identifier: NCT01898494.
13. HaugheyB, Washington University School of Medicine. Post operative adjuvant therapy de-intensification trial for human papillomavirus-related, p16+ oropharynx cancer (ADEPT). http://clinicaltrials.gov/show/NCT01687413. NLM Identifier: NCT01687413.